BARCLAYS PLC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 62 filers reported holding IRADIMED CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$472
+32.6%
10,656
+43.0%
0.00%
Q2 2023$356
-4.8%
7,453
-21.6%
0.00%
Q1 2023$374
+73.1%
9,502
+24.3%
0.00%
Q4 2022$216
-99.9%
7,646
+51.1%
0.00%
Q3 2022$152,000
-12.1%
5,059
-1.1%
0.00%
Q2 2022$173,000
-79.0%
5,115
-72.2%
0.00%
-100.0%
Q1 2022$825,000
-36.5%
18,388
-34.7%
0.00%
Q4 2021$1,300,000
+331.9%
28,158
+213.7%
0.00%
Q3 2021$301,000
+42.0%
8,975
+24.9%
0.00%
Q2 2021$212,000
-26.9%
7,184
-36.4%
0.00%
Q1 2021$290,000
+31.8%
11,301
+17.0%
0.00%
Q4 2020$220,000
+1.9%
9,660
-5.0%
0.00%
Q3 2020$216,000
-27.8%
10,169
-21.3%
0.00%
Q2 2020$299,000
+221.5%
12,922
+195.8%
0.00%
Q1 2020$93,000
-45.6%
4,369
-40.7%
0.00%
Q4 2019$171,000
+51.3%
7,362
+37.6%
0.00%
Q3 2019$113,000
+94.8%
5,352
+88.3%
0.00%
Q2 2019$58,000
-29.3%
2,843
-1.8%
0.00%
Q1 2019$82,000
+64.0%
2,896
+40.7%
0.00%
Q4 2018$50,0000.0%2,059
+53.9%
0.00%
Q3 2018$50,000
+108.3%
1,338
+21.5%
0.00%
Q2 2018$24,0001,101
+7764.3%
0.00%
Q1 2018$0
-100.0%
14
-98.9%
0.00%
Q1 2017$12,000
+500.0%
1,319
+689.8%
0.00%
Q4 2016$2,000
+100.0%
167
+351.4%
0.00%
Q3 2016$1,000
-99.8%
37
-99.8%
0.00%
-100.0%
Q4 2015$537,000
+322.8%
19,177
+260.8%
0.00%
Q3 2015$127,000
+12600.0%
5,315
+9742.6%
0.00%
Q2 2015$1,000540.00%
Other shareholders
IRADIMED CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 783,066$30,814,0005.13%
Soleus Capital Management, L.P. 773,694$30,444,8593.15%
RK Capital 335,400$13,197,9902.90%
Capital Impact Advisors, LLC 19,390$762,9970.94%
Ranger Investment Management 205,692$8,093,9800.54%
Bares Capital Management 317,000$12,473,9500.44%
Hillsdale Investment Management Inc. 109,100$4,293,0850.37%
CORNERCAP INVESTMENT COUNSEL INC 37,007$1,456,2250.26%
Riverwater Partners LLC 6,234$245,3080.22%
RICE HALL JAMES & ASSOCIATES, LLC 72,271$2,843,8640.16%
View complete list of IRADIMED CORP shareholders